A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

被引：1

作者：

Liu, Wei ^{[1
]}

Huang, Yunhong ^{[2
]}

Yang, Haiyan ^{[3
]}

Li, Zhiming ^{[4
]}

Cai, Zhen ^{[5
]}

Wang, Zhen ^{[6
]}

Liu, Lihong ^{[7
]}

Guo, Ye ^{[8
]}

Liu, Ligen ^{[9
]}

Huang, Rui ^{[10
]}

Ye, Xu ^{[11
]}

Qiu, Lugui ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Inst Hematol & Blood Dis Hosp,Haihe Lab Cell Ecos, Tianjin, Peoples R China

[2] Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Peoples R China

[3] Zhejiang Canc Hosp, Hangzhou, Peoples R China

[4] State Key Lab Oncol South China, Guangzhou, Peoples R China

[5] Zhejiang Univ, Sch Med, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Hangzhou, Peoples R China

[6] Linyi Canc Hosp, Linyi, Peoples R China

[7] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China

[8] Shanghai East Hosp, Shanghai, Peoples R China

[9] Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Shanghai, Peoples R China

[10] Southern Med Univ, Zhujiang Hosp, Guangzhou, Peoples R China

[11] Guangzhou Med Univ, Dept Hematol, Affiliated Hosp 2, Guangzhou, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-177550

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4